Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Carnosine

Beta-Ala-His Dipeptide

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

Carnosine is an endogenous dipeptide sold as a legal oral supplement, but its human evidence base is small and preliminary rather than established. Oral carnosine is largely hydrolyzed within minutes by serum carnosinase-1 (half-life under 5 minutes), so beta-alanine is the preferred way to raise muscle carnosine, and the human trials that do exist are mostly single small RCTs: a randomized glucose trial in prediabetes and type 2 diabetes (medRxiv preprint) signaled improved glycemic control, an anserine/carnosine aging trial signaled preserved prefrontal blood flow in APOE-e4 carriers, and a 36-child autism RCT (Ghodsi 2019) was null for glycation and lipoxidation markers.

FDA
Not an FDA-approved drug; sold and regulated as a dietary supplement in the United States
WADA
Not prohibited by WADA (neither carnosine nor beta-alanine appears on the Prohibited List)

Reference only. Not medical advice.

What can go wrong

Well tolerated at typical supplement doses; oral efficacy is limited because serum carnosinase hydrolyzes it within minutes, and most human benefit data come from small single trials.

Talk to a clinician before taking this. The Atlas can tell you what has been studied about Carnosine. It cannot tell you how it would interact with your body, your history, or anything else you are taking, and nothing on this page is a reason to start.

A naturally occurring dipeptide concentrated in muscle and brain, with anti-glycation, antioxidant, and pH-buffering properties. Studied for exercise performance, aging, and metabolic health. Available as an oral supplement.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Anti-glycation / aging
  • Exercise buffering
  • Metabolic health

How it is supposed to work

Carnosine is a small natural molecule, abundant in muscle and present in the brain, that the body uses as a multipurpose protector. It mops up damaging free radicals, blocks the sugar-driven protein damage called glycation, grabs reactive metal ions, and buffers acid in working muscle. Those properties make it a popular anti-aging, brain-health and athletic-performance supplement.

Carnosine is a dipeptide of beta-alanine and histidine, first isolated from meat in 1900 and named for it. It is sold as an oral supplement and, in a modified form, as cataract eye drops, and is one of the few non-injectable, food-derived compounds in this library.

Type
Natural dipeptide
Identity
Beta-alanyl-L-histidine
Found in
Muscle and brain
Oral catch
Degraded by carnosinase
Evidence
Promising, preclinical-led
Status
Supplement

Lovely Biochemistry, Undercut By The Enzyme That Digests It

Carnosine is one of those molecules whose test-tube properties are genuinely impressive: it is an effective antioxidant, a notable anti-glycation agent that blocks the advanced glycation end-products implicated in diabetes complications and Alzheimer’s, a metal chelator, and a muscle pH buffer, and it can even delay aging in cultured cells. The catch is delivery. When taken orally, much of the carnosine is rapidly chopped back into its two amino acids by an enzyme in the blood called carnosinase before it can reach muscle or brain, and how much survives varies from person to person. That is precisely why, for muscle and performance goals, the precursor beta-alanine, which reliably raises muscle carnosine and sidesteps the enzyme, is the better-evidenced choice. The preclinical and early-clinical results in diabetes, eye and brain health are promising, but human therapeutic relevance is not established, and the gap between carnosine’s biochemistry and what an oral dose actually delivers is the honest center of the story.

Safety in detail

Generally regarded as low-risk at common oral doses, though the intact dipeptide has poor systemic bioavailability; beta-alanine, the usual alternative for raising muscle carnosine, can cause transient paresthesia (skin tingling). N-acetylcarnosine eye drops are a separate product and are not interchangeable with oral carnosine.

  • As an endogenous dietary dipeptide it is very safe and well tolerated.
  • Its main limitation is poor and variable oral bioavailability, not harm.
  • Human therapeutic relevance across its many proposed uses is not established.
  • Individual carnosinase activity affects how much survives.

Children and teenagers

Carnosine is a food-derived supplement without specific pediatric indications, and there is no established reason for pediatric supplementation.

What people get wrong

Nothing recorded here yet. There is almost certainly something people get wrong about this one, and the blank space means we have not written it down, not that the record is clean.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

Carnosine reaches users through the supplement market, sold as oral capsules for anti-aging and brain health and as eye drops for cataracts, with beta-alanine sold alongside it for performance. It is a mainstream consumer category whose marketing leans on strong biochemistry more than on settled human outcomes.

How we got here

Carnosine was isolated from meat extract in 1900 by Russian chemist Vladimir Gulevich, who named it after the Latin carnis (flesh), reflecting its high concentration in skeletal muscle and its dietary origin in meat. Its close methylated relative anserine was characterized soon after, and the two are often studied and sold together (notably in chicken-breast and fish-derived anserine/carnosine blends popular in Japanese aging research). Because serum carnosinase rapidly degrades ingested carnosine, the sports-nutrition market pivoted to beta-alanine (branded CarnoSyn among others) as the rate-limiting precursor used to load muscle carnosine, so much of what is sold today as a carnosine strategy is delivered as beta-alanine rather than the intact dipeptide. The acetylated derivative N-acetylcarnosine was later developed and commercialized specifically as a cataract eye drop under names such as Can-C, a lineage that is often conflated with oral L-carnosine but is a distinct compound and product.

Carnosine was discovered in 1900 in meat extracts and studied for decades for its role in muscle and exercise, later gaining attention for antioxidant, anti-glycation and neuroprotective properties and a place in anti-aging and performance supplementation, alongside its precursor beta-alanine.

The numbers behind the grade

Type
Natural dipeptide
Found in
Muscle, brain
Action
Antioxidant, anti-glycation
Oral catch
Carnosinase
Evidence
Promising
Status
Supplement

The people taking it

A natural muscle-and-brain dipeptide with impressive antioxidant and anti-glycation biochemistry, whose oral form is undercut by an enzyme that breaks it down before it reaches its targets.

Carnosine’s users are anti-aging and brain-health supplement takers, athletes and active people, and those interested in its anti-glycation angle for metabolic aging.

A widely-used oral and eye-drop supplement for anti-aging, brain and eye health and performance, with strong biochemistry but a real oral-bioavailability limitation and unsettled human evidence.

Set against the alternatives

Carnosine’s most important comparison is with its own precursor, beta-alanine, which for muscle and performance goals is better evidenced and cheaper because it raises muscle carnosine while sidestepping the enzyme that degrades oral carnosine. Against the master antioxidant peptide glutathione, it is another small protective peptide with its own delivery challenges. Against the other oral supplement here, Collagen Tripeptide, it shares the food-grade dipeptide nature but with a less settled human evidence base. Its strength is versatile biochemistry; its limit is getting intact to its targets.

What we do not know

  • Whether enough oral carnosine survives to produce its proposed systemic effects.
  • Whether its promising diabetes, eye and brain results translate into established human benefit.
  • How individual carnosinase differences change who responds.

What could change

Delivery solutionsResearch explores forms that resist carnosinase degradation.Disease translationTrials probe diabetes complications, eye disease and neurodegeneration.Precursor strategyBeta-alanine remains the validated route for raising muscle carnosine.Brain signalingWork continues on carnosine’s role in brain and hypothalamic signaling.

The market for this

What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.

Carnosine is a safe, well-studied molecule whose oral form is undercut by the enzyme that degrades it before it reaches muscle or brain. Anyone whose goal is athletic performance is usually better served by its precursor beta-alanine, while those pursuing its anti-glycation or brain-health angles should treat the human evidence as promising but unsettled and keep expectations modest.

It is inexpensive to moderately priced, with beta-alanine often the more cost-effective choice for muscle goals.

Carnosine is produced synthetically for supplements and eye drops, with quality varying between brands.

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Carnosine.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Supply chain. We have not mapped where it is made.

Sources

The studies that matter

  • Biochemistryestablished

    Carnosine is an antioxidant, anti-glycation agent, metal chelator and muscle pH buffer.

  • Cellular anti-agingpreclinical

    It can delay senescence and rejuvenate cultured human fibroblasts.

  • Bioavailability catchestablished

    Oral carnosine is largely broken down by serum carnosinase before reaching muscle or brain.

  • Beta-alanine alternativewell-documented

    Its precursor beta-alanine reliably raises muscle carnosine and bypasses the enzyme for performance goals.